MacroGenics, Inc.
MGNX
$1.40
-$0.02-1.41%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -34.21% | 105.99% | 44.90% | 80.53% | 964.81% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -34.21% | 105.99% | 44.90% | 80.53% | 964.81% |
| Cost of Revenue | 4.44% | -8.90% | -6.33% | -6.60% | 26.64% |
| Gross Profit | -58.21% | 37.25% | 18.28% | 31.98% | 395.74% |
| SG&A Expenses | -29.77% | -35.51% | -27.13% | 121.42% | 13.66% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.09% | -14.47% | -11.20% | 20.17% | 23.13% |
| Operating Income | -65.61% | 36.82% | 20.70% | -7.06% | 252.64% |
| Income Before Tax | -70.13% | 35.06% | 21.37% | 68.58% | 220.78% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -70.13% | 34.88% | 21.37% | 66.53% | 220.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -70.13% | 34.88% | 21.37% | 66.53% | 220.78% |
| EBIT | -65.61% | 36.82% | 20.70% | -7.06% | 252.64% |
| EBITDA | -63.54% | 38.17% | 21.30% | -7.02% | 266.98% |
| EPS Basic | -70.36% | 35.36% | 22.21% | 66.93% | 216.88% |
| Normalized Basic EPS | -70.35% | 35.55% | 22.23% | -8.81% | 216.89% |
| EPS Diluted | -70.36% | 35.36% | 22.21% | 66.59% | 220.50% |
| Normalized Diluted EPS | -70.33% | 35.55% | 22.23% | -8.81% | 217.53% |
| Average Basic Shares Outstanding | 0.78% | 0.75% | 1.08% | 1.19% | 1.23% |
| Average Diluted Shares Outstanding | 0.66% | 0.75% | 1.08% | 1.19% | 1.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |